Alkeon Capital Management Portfolio holdings
AUM
$20.6B
This Quarter Return
-8.05%
1 Year Return
+8.97%
3 Year Return
+43.14%
5 Year Return
+49.88%
10 Year Return
+256.15%
AUM
$16.7B
AUM Growth
-$5.62B
(-25%)
Cap. Flow
-$830M
Cap. Flow
% of AUM
-4.98%
Top 10 Holdings %
Top 10 Hldgs %
34.41%
Holding
139
New
4
Increased
40
Reduced
57
Closed
5
Top Buys
| 1 |
ASML
ASML
|
$330M |
| 2 |
Meta Platforms (Facebook)
META
|
$285M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$260M |
| 4 |
Baidu
BIDU
|
$145M |
| 5 |
New Oriental
EDU
|
$102M |
Top Sells
| 1 |
Sony
SONY
|
$462M |
| 2 |
RTX Corp
RTX
|
$240M |
| 3 |
Gartner
IT
|
$199M |
| 4 |
Alibaba
BABA
|
$180M |
| 5 |
Equifax
EFX
|
$140M |
Sector Composition
| 1 | Technology | 43.85% |
| 2 | Consumer Discretionary | 16.61% |
| 3 | Communication Services | 12.5% |
| 4 | Financials | 12.02% |
| 5 | Real Estate | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Peloton Interactive
PTON
$3.1B
| $38.9M | 0.1% |
4,234,254
+677,929
| +19% | +$6.22M |
|
77
Marqeta
MQ
$2.77B
| $37.4M | 0.1% |
4,616,647
+421,599
| +10% | +$3.42M |
|
78
Cintas
CTAS
$82.9B
| $35.2M | 0.09% |
376,532
-726,480
| -66% | -$67.8M |
|
79
Keros Therapeutics
KROS
$638M
| $32.5M | 0.09% |
1,176,433
+270,000
| +30% | +$7.46M |
|
|
CERE
80
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $32M | 0.09% |
1,210,979
-486,397
| -29% | -$12.9M |
|
81
Zillow
Z
$20.2B
| $26.1M | 0.07% |
820,584
-1,567,765
| -66% | -$49.8M |
|
82
Schrodinger
SDGR
$1.42B
| $25.6M | 0.07% |
968,608
-16,204
| -2% | -$428K |
|
83
Akero Therapeutics
AKRO
$3.65B
| $24.8M | 0.07% |
2,619,671
+200,000
| +8% | +$1.89M |
|
84
PMV Pharmaceuticals
PMVP
$82.1M
| $21.7M | 0.06% |
1,519,935
-79,618
| -5% | -$1.13M |
|
85
JFrog
FROG
$5.58B
| $20.5M | 0.06% |
973,069
-15,937
| -2% | -$336K |
|
|
IGMS
86
DELISTED
IGM Biosciences
IGMS
| $18.6M | 0.05% |
1,034,035
| – | – |
|
87
Xometry
XMTR
$2.37B
| $15.5M | 0.04% |
457,621
+93,454
| +26% | +$3.17M |
|
88
Avidity Biosciences
RNA
$6.12B
| $12.4M | 0.03% |
856,466
| – | – |
|
89
BioCryst Pharmaceuticals
BCRX
$1.74B
| $12.4M | 0.03% |
1,168,345
-19,500
| -2% | -$206K |
|
90
Procore
PCOR
$10.3B
| $11.5M | 0.03% |
253,840
-4,281
| -2% | -$194K |
|
|
KLRS
91
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $10.7M | 0.03% |
119,735
+86,956
| +265% | +$7.8M |
|
|
ALTR
92
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $10.2M | 0.03% |
193,919
-3,227
| -2% | -$169K |
|
93
Oric Pharmaceuticals
ORIC
$1.03B
| $9.44M | 0.03% |
2,106,968
+200,000
| +10% | +$896K |
|
94
Apple
AAPL
$3.54T
| $7.74M | 0.02% |
56,627
-984,651
| -95% | -$135M |
|
95
TG Therapeutics
TGTX
$5.03B
| $7.51M | 0.02% |
1,767,130
-30,880
| -2% | -$131K |
|
96
Rhythm Pharmaceuticals
RYTM
$6.75B
| $6.23M | 0.02% |
+1,500,000
| New | +$6.23M |
|
97
Stem
STEM
$122M
| $5.49M | 0.01% |
38,340
-662
| -2% | -$94.8K |
|
98
Caribou Biosciences
CRBU
$176M
| $4.74M | 0.01% |
873,549
-350,000
| -29% | -$1.9M |
|
|
AVYA
99
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $4.74M | 0.01% |
2,115,648
-2,445,393
| -54% | -$5.48M |
|
|
100
Sony
SONY
$162B
| $4.5M | 0.01% |
275,000
-28,229,500
| -99% | -$462M |
|